20th week of 2009 patent applcation highlights part 38 |
Patent application number | Title | Published |
20090123529 | NUCLEIC ACID IMMUNOLOGICAL COMPOSITION FOR HUMAN METAPNEUMOVIRUS - There is provided an immunological composition that comprises a nucleic acid vector which includes a promoter region operably linked to a coding sequence encoding the human metapneumovirus F antigen or the human metapneumovirus G antigen. The immunological composition is useful for administering to an individual to elicit an immune response to human metapneumovirus in the individual and for the generation of diagnostic reagents for hMPV. | 2009-05-14 |
20090123530 | Liposome Drug Delivery - This invention comprises pharmaceutical compositions for administering a biologically active compound to an animal. Particularly provided are proliposomal compositions that are advantageously used to deliver biologically active compounds to the gastrointestinal tract after oral administration. | 2009-05-14 |
20090123531 | GLUTATHIONE-BASED DELIVERY SYSTEM - A delivery system is provided. The delivery system includes a carrier or an active compound and a glutathione or a glutathione derivative grafted thereon. The invention also provides a compound including a moiety comprising a vitamin E derivative or a phospholipid derivative, a polyethylene glycol (PEG) or a polyethylene glycol derivative bonded thereto, and a glutathione (GSH) or a glutathione derivative bonded to the polyethylene glycol or the polyethylene glycol derivative. | 2009-05-14 |
20090123532 | OLIGONUCLEIC ACID-BEARING COMPOSITE AND PHARMACEUTICAL COMPOSITION CONTAINING THE COMPOSITE - The present invention provides a complex, which comprises a cationic liposome comprising 2-O-(2-diethylaminoethyl)carbamoyl-1,3-O-dioleoylglycerol and a phospholipid as main ingredients, and an oligo nucleic acid which is carried on the liposome. Also, the present invention provides a pharmaceutical composition containing the complex to be used for treating or preventing diseases caused by a target molecule of the oligo nucleic acid (target DNA, target RNA, target protein) since it is possible to administer the complex in vivo and to put the complex into practical use as a medicament because the complex can exhibit pharmacological efficacy in vivo. | 2009-05-14 |
20090123533 | Compositions and methods for cancer diagnosis and therapy - The miR15 and miR16 micro RNA genes are located at 13q14 within a 30 kb region of loss characteristic of cells from certain cancers, such as cells from chronic lymphocytic leukemia or prostate cancer. Chronic lymphocytic leukemia or prostate cancer can be diagnosed by detecting a reduction in miR15 or miR16 gene copy number, by determining miR15 or miR16 gene mutational status, or by detecting a reduction in the RNA transcribed from these genes. The miR15 or miR16 gene products can inhibit the neoplastic or tumorigenic growth of cancers such as chronic lymphocytic leukemia or prostate cancer cells when administered to subjects suffering from these diseases. | 2009-05-14 |
20090123534 | Pharmaceutical composition based on micronized progesterone, preparation method and uses thereof - The present invention relates to a pharmaceutical composition comprising micronized progesterone, soya bean lecithin, and at least one oil selected from the group consisting of sunflower oil, olive oil, sesame seed oil, colza oil, almond oil, to the method for the preparation thereof and to the uses thereof for treating a physiological condition linked to insufficiency of progesterone secretion. | 2009-05-14 |
20090123535 | Oral Controlled Release Formulation for Sedatives and Hypnotic Agents - The present invention relates to a novel controlled release dosage form that releases therapeutic amounts of a sedative or hypnotic agent rapidly after administration and maintains therapeutic levels for about eight hours after administration. | 2009-05-14 |
20090123536 | Oral Pharmaceutical Form of Losartan - The field of the present invention is that of oral pharmaceutical forms of losartan, and also treatments and administration methods relating thereto. | 2009-05-14 |
20090123537 | ORAL DOSAGE FORM OF CEFTRIAXONE AND METHODS OF USE - The present invention contemplates a novel oral dosage form for the intestinal delivery of ceftriaxone sodium. The oral dosage form inhibits enteric degradation of the therapeutic compound by encapsulation within an inner core region and having an outer shell, preventing its dissolution until reaching the small intestine. Furthermore, the enzymatic degradation of the compound is substantially inhibited until absorption at the intestinal mucosa. | 2009-05-14 |
20090123538 | Angiotensin II Receptor Antagonists - The compounds of the present invention are polymorphic crystalline forms of the compound 2-butyl-4-chloro-1-[(2′-(1-H-tetrazol-5-yl)biphenyl-4-yl)methyl]-imidazole-5-carboxylic acid, which has the structure (I). Specifically, the compounds of the invention are selected from the group consisting of 2-butyl-4-chloro-1-[(2′-(1-H-tetrazol-5-yl)biphenyl-4-yl)methyl]-imidazole-5-carboxylic acid of Claim | 2009-05-14 |
20090123539 | WET GRANULATION USING A WATER SEQUESTERING AGENT - Disclosed are tablets comprising hydrolytically stable formulations of (6-(5-fluoro-2-(3,4,5-trimethoxyphenylamino) pyrimidin-4-ylamino)-2,2-dimethyl-3-oxo-2H-pyrido[3,2-b][1,4]oxazin-4(3H)-yl)methyl phosphate disodium salt (Compound 1) prepared by a wet granulation process. | 2009-05-14 |
20090123540 | Sulfoalkyl Ether Cyclodextrin Compositions and Methods of Preparation Thereof - A particulate SAE-CD composition is provided. The SAE-CD composition has an advantageous combination of physical properties not found in known solid forms of SAECD. In particular, the SAE-CD composition possesses an advantageous physicochemical and morphological property profile such that it can be tailored to particular uses. The SAE-CD composition of the invention has improved flow and dissolution performance as compared to known compositions of SAE-CD. | 2009-05-14 |
20090123541 | Pharmaceutical Composition - The present invention relates to an oral controlled release pharmaceutical composition in the form of a unit dosage form comprising:
| 2009-05-14 |
20090123542 | PRIMARY COMPOSITION COMPRISING A LIPOPHILIC BIOACTIVE COMPOUND - The invention relates to a primary composition in which at least one lipophilic bioactive compound is mixed with a whey protein, present in an amount effective to increase the bioavailability of the lipophilic bioactive compound. The invention also relates to an oral composition that contains the primary composition in a foodstuff, in a food supplement, or in a pharmaceutical preparation, and to a cosmetic preparation that contains the primary composition. Methods for increasing the bioavailability of the lipophilic bioactive compound and providing increased photostability and oxidation resistance are also provided. | 2009-05-14 |
20090123543 | PHARMACEUTICAL COMPOSITIONS - A novel solid oral dosage form comprising a therapeutically effective amount of hydrophobic pharmacological active ingredient and at least one particle separating agent preferably selected from a class of wetting agents, prepared without or with minimum amount of a disintegrating agent. The hydrophobic pharmacological active ingredient active ingredient belongs to the class of angiotensin receptor blocking agents preferably is valsartan optionally in combination with hydrochlorothiazide. The active ingredient may also be a class of 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase inhibitors preferably atorvastatin. The ratio of hydrophobic active ingredient to particle separating agent is about 20:1 to about 1:20. The process for the preparation of the novel solid oral dosage form comprises treating a hydrophobic active ingredient with at least one particle separating agent, and incorporating the treated hydrophobic active ingredient into a solid dosage form. | 2009-05-14 |
20090123544 | STIMULUS-RESPONSIVE BIODEGRADABLE POLYMERS AND METHODS OF PREPARATION - There is presently provided a stimulus-responsive polymer comprising a biodegradable polymer backbone and a stimulus-responsive pendant group attached to the biodegradable polymer backbone, wherein the biodegradable polymer backbone comprises a poly(amino ester) or a poly(amido amine), the poly(amido amine) optionally comprising a disulfide linkage in the backbone. | 2009-05-14 |
20090123545 | Rapid Onset and Short Term Modafinil Compositions and Methods of Use Thereof - Compositions are described that comprise a modafÊnil component that is a combination of the d- and l-enantiomers of modafinil and wherein the modafÊnil component is greater than 50% by weight d-modafÊnil for use in promoting or enhancing the state of wakefulness, alertness, and/or central nervous system stimulation in an individual. | 2009-05-14 |
20090123546 | Polymer-based, sustained release drug delivery system - Disclosed is a sustained release system that includes a polymer and a pharmaceutically active agent dispersed in the polymer. The agent is in granular or particulate form, and has a rate of release from the system that is limited primarily by the rate at which the agent dissolves from the granules into the polymer matrix. Advantageously, the polymer is permeable to the agent and is non-release-rate-limiting with respect to the rate of release of the agent from the polymer. | 2009-05-14 |
20090123547 | Methods and Compositions for Regenerating Connective Tissue - Connective tissue regenerative compositions and methods of repairing and regenerating connective tissue using such compositions are provided. The compositions generally comprise a bioactive hydrogel matrix comprising a polypeptide, such as gelatin, and a long chain carbohydrate, such as dextran. The hydrogel matrix may further include polar amino acids, as well as additional beneficial additives. Advantageously, the compositions include further components, such as osteoinductive or osteoconductive materials, medicaments, stem or progenitor cells, and three-dimensional structural frameworks. The compositions are useful for regenerating connective tissue, and can be administered to an area having injury to, or a loss of, connective tissue, such as bone, cartilage, tendon, and ligament. | 2009-05-14 |
20090123548 | Device for administering aromatherapy - A device for administering aromatherapy to a subject and the method of using the device are disclosed. The device comprises an aromatherapy composition housed within a container. The container has at least one opening or aperture through which the subject may breathe in or inhale the aromatic and volatile components of the aromatherapy composition through the mouth and/or nose. The aromatherapy composition comprises a particulate component comprising one or more irregularly- or regularly-shaped particles, granules, beads or the like. In addition, the aromatherapy composition has a volatile component comprising an amount of an essential oil-containing composition. The volatile component is that portion of the essential oil-containing composition that is retained by the particulate component after contacting the particulate component with the essential oil-containing composition and removal of the portion that is not retained by the particulate component. | 2009-05-14 |
20090123549 | Pharmaceutical Compositions - A composition comprising a pharmaceutically acceptable group (2, 4, 12, 13 or 14) metal compound for the treatment of a dermatological condition involving an abnormal decrease in the cell-to-cell adhesion between epithelial cells in the epidermal barrier. | 2009-05-14 |
20090123550 | CORTICOSTEROID COMPOSITIONS - Provided herein are methods for treating, preventing or alleviating the symptoms of and inflammation associated with inflammatory diseases and conditions of the gastrointestinal tract, for example, those involving the esophagus. Also provided herein are pharmaceutical compositions useful for the methods of the present invention. | 2009-05-14 |
20090123551 | GASTROINTESTINAL DELIVERY SYSTEMS - Provided herein are compositions suitable for the delivery of therapeutic agents to the gastrointestinal tract. Also provided herein are methods for treating, preventing or alleviating disorders of the gastrointestinal tract, for example, those involving the esophagus, by orally administering compositions described herein. | 2009-05-14 |
20090123552 | SPHEROIDS PREPARED FROM AN ISOLATED ACTIVE PRINCIPLE OF VEGETABLE ORIGIN AND A SOLUTION OF VEGETABLE ORIGIN CONTAINING THE ACTIVE PRINCIPLE OR A PRECURSOR THEREOF - The invention relates to spheroids which are obtained using a method comprising the following steps consisting in: supplying an active principle of vegetable origin in an isolated form; supplying a solution of vegetable origin, containing the active principle or a precursor thereof; supplying an absorbing and adsorbing substance having plastic properties that are compatible with the method; mixing said different products and wetting the mixture with a wetting liquid; extruding the wet mixture; and forming spheroids through the spheronization of the extruded product. The invention also relates to sample applications such as artesunate-based antimalarial spheroids and aspring-based spheroids. | 2009-05-14 |
20090123553 | Peptide nanostructures and methods of generating and using the same - A tubular or spherical nanostructure composed of a plurality of peptides, wherein each of the plurality of peptides includes no more than 4 amino acids and whereas at least one of the 4 amino acids is an aromatic amino acid. | 2009-05-14 |
20090123554 | Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations - The invention is directed to oral modified/controlled release drug formulations which provide a rapid initial onset of effect and a prolonged duration of effect. Preferably, the peak concentration is lower than that provided by the reference standard for immediate release formulations of the drug, and the duration of effect falls rapidly at the end of the dosing interval. | 2009-05-14 |
20090123555 | Stimulateable Polymer Particles Exhibiting Reactive Functions, Method for the Production and the Use Thereof - The invention relates to spherical particles formed by polymer chains containing approximately from 30 to 10000 monomer units derived from monocyclic polycyclic alkene polymerization, wherein at least one monomer unit is substituted by an R chain including ethylene polyoxide which is optionally covalently linked to the polymer units through a hydrolyzable bridge and substituted by a reactive function, optionally engaged in a link with an active principle or a biological molecule such as protein, wherein the chain R is covalently linked to the monomer units. The use of the inventive spherical particles for preparing pharmaceutical and cosmetic compositions or surface coatings is also disclosed. | 2009-05-14 |
20090123556 | SUSTAINED RELEASE PHARMACEUTICAL COMPOSITIONS - The present invention provides a sustained release microsphere composition comprising | 2009-05-14 |
20090123557 | DIETARY SUPPLEMENT COMPOSITION FOR BLOOD LIPID HEALTH - A method for enhancing gastrointestinal motility in humans and other mammals comprises administering a therapeutically effective amount of a composition having one or more long chain (C24-C36) primary alcohols as policosanols dispersed in one or more food-grade fats or oils, wherein the particle sizes of the alcohols are substantially less than 10 microns. | 2009-05-14 |
20090123558 | Polarized Scorpion Venom Solution and a Method for Making Polarized Scorpion Venom Solution - Various embodiments of this invention disclose a polarized dilute blue scorpion venom solution, a method for making a polarized dilute scorpion venom solution, and a method for administering dilute scorpion venom solution. The polarized dilute scorpion venom solution relieves pain, improves immune-system response, treats cancer, prevents cancer, improves quality of sleep, reduces inflammation, and minimizes negative biological response to chemotherapy and radiation treatment. | 2009-05-14 |
20090123559 | Medicine to Treat Drug Addiction and Preparation Method Thereof - The present invention declares a pharmaceutical extract, composition that has effect to treat drug addiction, and its preparation method and quality control method. This extract is extracted from Radix Stephaniae Epigaeae. Starting medicine material of said composition is Radix Ginseng, Radix Astragali, Rhizoma Corydalis, Radix Angelicae Sinensis and Radix Ophiopogonis; and said composition also can prepared by ethanol extract of Radix Ginseng, ethanol extract of Radix Angelicae Sinensis, total alkaloids of Radix Stephaniae Epigaeae, water extract of Radix Astragali and water extract of Radix Ophiopogonis. Quality control method of said pharmaceutical composition includes one of or several of identifications and content determinations. The present invention also declares the use of said pharmaceutical extract, composition in the preparation of a medicine to treat drug addiction. | 2009-05-14 |
20090123560 | Hematopoietic Stem Cell Proliferation Inducing Agent - Disclosed is a hematopoietic stem cell proliferation inducing agent which comprises a pulverized product of placenta-constituting cells as an active ingredient and can induce/proliferate a hematopoietic stem cell in the peripheral blood. Since the proliferation inducing agent can induce/proliferate a hematopoietic stem cell to increase the amount of hematopoietic stem cells in the peripheral blood, it becomes possible to ensure the increase in the amount of hematopoietic stem cells in the peripheral blood. The proliferation inducing agent can be used for the prevention and treatment of various diseases which are caused or believed to be caused by the decrease in the amount of hematopoietic stem cells (e.g., leukemia, malignant lymphoma, aplastic anemia, Alzheimer's disease, Parkinson's disease, dilated cardiomyopathy, myocardial infarction) and produces extremely small adverse side effects. | 2009-05-14 |
20090123561 | Fungicide mixtures based on 1-methyl-pyrazol-4-ylcarboxanilides - Fungicidal mixtures, comprising as active components
| 2009-05-14 |
20090123562 | Pharmaceutical Formulations of Gallium Salts - The present invention relates to pharmaceutical formulations containing a pharmaceutically acceptable gallium salt (such as gallium nitrate), a delivery agent, and optionally, one or more chemotherapeutic agents and/or adjunctive chemotherapeutic agents. | 2009-05-14 |
20090123563 | Pharmaceutical Preparations Comprising Insulin, Zinc Ions and Zinc-Binding Ligand - Novel preparations comprising branched ligands for the HisB10 Zn2+ sites of the R-state insulin hexamer. The preparations have a prolonged action designed for flexible injection regimes. | 2009-05-14 |
20090123564 | NOVEL COMPOSITIONS FOR HAIR DISORDERS AND PROCESS OF PREPARATION THEREOF - Novel compositions for hair loss prevention and/or hair growth promotion comprising at least active agent preferably derived from natural source such as from the plant | 2009-05-14 |
20090123565 | Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto - The present invention relates to the discovery that non-traditional export of certain pro-inflammatory cytokines lacking a signal sequence from a cell can be inhibited by copper chelation and/or administration to the cell of a truncated form of S100A13 lacking the basic residue portion. Further, copper chelation inhibits, inter alia, neointima formation, macrophage infiltration and associated inflammation, cell proliferation, secretion of extracellular matrix, intimal thickening, adventitial angiogenesis, restenosis, and the like, associated with vascular vessel injury. Thus, the present invention provides novel methods of preventing and treating, and for identifying novel compounds also useful as therapeutics for, such conditions. | 2009-05-14 |
20090123566 | USE OF A PHOSPHATE ADSORBENT TO COMBAT VASCULAR DISEASES - The invention relates to the use of an adsorption material which has been modified with polynuclear metal oxide hydroxides for influencing the calcium level and, in particular, for treating or/and preventing atherosclerotic vascular diseases or/and disturbances of bone metabolism. | 2009-05-14 |
20090123567 | BISBENZISOSELENAZOLONYL DERIVATIVES HAVING ANTINEOPLASTIC, ANTI-INFLAMMATORY AND ANTITHROMBOTIC ACTIVITIES AS WELL AS THEIR USE - The present invention relates to new bisbenzisoselenazolonyl derivatives of the following general formula (I), wherein R is C | 2009-05-14 |
20090123568 | KIT USEFUL FOR TREATING TUMORS AND LESIONS OF THE SKIN AND THE MUCOUS MEMBRANES - The pharmaceutical preparation useful for treating a skin or mucous membrane lesion is provided. The pharmaceutical preparation including, as active ingredients, a therapeutically effective amount of trichloroacetic acid and hydrochloric acid, or trichloroacetic acid and formic acid or all three of these acids and optionally a crosslinking/fixating/preserving agent. Additional preparations are also described. | 2009-05-14 |
20090123569 | Coverage indicating technology for skin sealants using tannates - A composition having various color changing tannates may be used to indicate that the composition has dried. The tannates change color in contact with an acid. The composition may be, for example, a skin prep, skin sealant, food product, paint or other building material or other product that undergoes a phase change. The tannate may be added either directly to the composition, incorporated into a sponge on an applicator through which the composition is dispensed and applied, applied separately or applied simultaneously from a separate reservoir. The amount of tannate in the composition can be adjusted to provide a visual cue to the user of the application area and the extent of cure. | 2009-05-14 |
20090123570 | COMPOSITION AND METHOD FOR TREATING SORE THROAT - The present invention provides compositions and methods for treating sore throat by reducing inflammation and clearing oral-pharyngeal mucus associated with sore throat comprising hypertonic saline and menthol. | 2009-05-14 |
20090123571 | Method of treating men with testosterone supplement and 5alpha-reductase inhibitor - A method of treating Alzheimer's disease, Parkinson's disease, sexual dysfunction or erectile dysfunction in a man by administration of a 5alpha reductase inhibitor together with a testosterone supplement is described. The method is also concerned with the use of the 5alpha reductase inhibiting compound and the testosterone supplement together with another agent useful for treating erectile dysfunction, including PDE V inhibitors; AGE (advanced glycation end-product) breakers; alpha 1 blockers; alpha 1A antagonists; alpha 2 antagonists; dopamine agonists; dopamine D4 agonists; melanocortin agonists; oxytocin agonists; prostaglandin; radical scavengers; rotamase inhibitors; aviptadil; nitroglycerine; and GPCR agonists for treating male sexual dysfunction or erectile dysfunction. | 2009-05-14 |
20090123572 | Method and Pharmaceutical Composition for Treating Psoriasis, Squamous Cell Carcinoma and/or Parakeratosis by Inhibiting Expression of Squamous Cell Carcinoma-Related Antigen - In a first aspect thereof, the present invention provides a method for treatment and/or prevention of a disease selected from the group consisting of psoriasis and squamous cell carcinoma by inhibiting the expression of squamous cell carcinoma antigen (SCCA) by cells. In another aspect thereof, the present invention provides a method for screening for substances that inhibit epidermal parakeratosis, wherein the activity of a candidate substance that inhibits cysteine protease inhibitory activity possessed by squamous cell carcinoma antigen 1 (SCCA-1) is used as an indicator. | 2009-05-14 |
20090123573 | ADMIXTURE OF EXTRACTS OF PLANTS OF THE GENUS ROSMARINUS AND CAROTENOIDS FOR TREATING CUTANEOUS SYMPTOMS OF AGING - Intimate admixtures of at least one carotenoid and at least one extract of at least one plant of the genus | 2009-05-14 |
20090123574 | Compositions for the regression of spongiform pustules - Herbal compositions that, when used topically in a therapeutically effective amount, are safe and effective for the regression of spongiform pustules in patients exhibiting chronic inflammatory skin disorders, such as psoriasis. The compositions, which can be formulated as ointments, oils, soaps and shampoos, comprise a non-aqueous herbal extract of | 2009-05-14 |
20090123575 | Blended Compositions for Treatment of Alzheimer's Disease and Other Amyloidoses - Methods for treating amyloid disease in a patient wherein the method comprises administration of a therapeutically effective amount of a composition comprising | 2009-05-14 |
20090123576 | ACTIVE SUBSTANCE COMBINATIONS OF ANISE FRUIT EXTRACT AND WHITE TEA EXTRACT - An active substance combination which comprises anise fruit extract and white tea extract and a cosmetic preparation comprising same. This Abstract is not intended to define the invention disclosed in the specification, nor intended to limit the scope of the invention in any way. | 2009-05-14 |
20090123577 | LIQUID CONCENTRATE FOR PRESERVING COSMETICS - The invention relates to a liquid concentrate for preserving cosmetic products which comprises a combination of carboxylic acid salts chosen from the salts of benzoic acid, propionic acid, salicylic acid, sorbic acid, 4-hydroxybenzoic acid, dehydracetic acid, formic acid or 10-undecylenic acid and alcohols chosen from 2-phenoxyethanol, benzyl alcohol, phenethyl alcohol, 1-phenoxypropan-2-ol, 3-(4-chlorophenoxy)-1,2-propanediol, chlorobutanol or 2,4-dichlorobenzyl alcohol in a solvent, where the active ingredient content is greater than 45% by weight. | 2009-05-14 |
20090123578 | SKIN CARE COMPOSITIONS WITH BOTANIC SEED OILS - A topical skin care composition with a base skin care composition suitable for application to skin, and blends of botanic seed oils, prepared according to a cold press method. The base skin care composition uses a multivesicular emulsion skin care delivery system as a base skin care composition. A micelle skin care delivery system is another base skin care composition used in the topical composition. The selected base skin care composition has a range of about 99.9% (% w/w) to 98% (% w/w) of the topical skin care composition, and range of about 0.1 (% w/w) to 2% (% w/w) of blends of botanic seed oil having red raspberry seed oil, and plurality of botanic oils selected from the group consisting of the following seed oils: pumpkin seed oil, chardonnay grape seed oil, carrot seed oil, blueberry seed oil, cranberry seed oil, pomegranate seed oil, black cumin seed oil, and black raspberry seed oil. | 2009-05-14 |
20090123579 | METHOD OF PROMOTING WEIGHT LOSS - Compositions for enhancing satiety and weight loss in an individual, assays for assessing a tastant for enhancing satiety and weight loss, and methods of using the composition to suppress appetite and enhance weight loss are provided. | 2009-05-14 |
20090123580 | METHODS FOR TREATING OBESITY, INSULIN RESISTANCE AND INDUCING SATIETY - The present invention provides a method for treating an insulin resistance disorder, treating obesity, reducing the weight and/or preventing weight gain and controlling appetite and/or inducing satiety in a subject by administering to the subject an amount of a stabilized rice bran solubilized fraction effective to treat the subject. | 2009-05-14 |
20090123581 | COLLAGEN CROSS-LINKING AGENTS ON DENTAL RESTORATIVE TREATMENT AND PREVENTIVE DENTISTRY - The invention relates to the development of compositions and methods for increasing the amount of collagen cross-linking in a mammalian tissue. A typical composition as described herein includes at least one cross-linking agent such as a bioflavonoid compound (e.g., proanthocyanidin), a grape seed extract, a Casein Phosphopeptide-amorphous Calcium Phosphate, or an iridoid compound (e.g., genipin) in an amount effective for increasing collagen cross-linking in the mammalian tissue in a pharmaceutically acceptable carrier. A typical method for increasing the amount of collagen cross-linking in dentin in a mammalian tooth includes the steps of preparing the surface of the tooth to be treated; and applying a composition including at least one of: a bioflavonoid compound, a grape seed extract, a Casein Phosphopeptide-amorphous Calcium Phosphate, and an iridoid compound in a pharmaceutically acceptable carrier to the tooth surface for a time period of 0.0001 hours to about 4 hours. In some embodiments, two or more cross-linking agents are included in the compositions described herein. The compositions and methods as described herein are particularly useful for applying to dentin in a mammalian tooth requiring a restorative procedure for improving the mechanical properties of restoration interfaces to withstand degradation over time. Compositions containing one of the collagen cross-linking agents as described herein were applied to dentin collagen and resulted in a significant improvement in ultimate tensile strength indicating the value of these compositions in restorative dentistry. The compositions and methods described herein will also find use in preventive dentistry applications, and can be applied to sound dentin, caries-affected dentin, and dentin that is impaired, weak, or degraded in any way. | 2009-05-14 |
20090123582 | Ameliorating Agent for Metabolic Syndrome - The object is to provide a food-derived effective ingredient which can promote the reduction in accumulated fats or the like. Disclosed is a body fat reduction-promoting agent, a leptin production-promoting agent, an anorexigenic agent, a PAI-1 production-suppressing agent or an anti-thrombotic agent, each comprising an extract from a chestnut astringent skin as an active ingredient. The extract from a chestnut astringent skin, which is a natural component, can be used as an extremely safe body fat reduction-promoting agent, leptin production-promoting agent, anorexigenic agent, PAI-1 production-suppressing agent or anti-thrombotic agent. Particularly, the body fat reduction-promoting agent can reduce an accumulated visceral fat and therefore can directly prevent obesity. | 2009-05-14 |
20090123583 | Method for Obtaining Fruit Wax - The invention relates to a method for obtaining fruit wax from plant constituents, said method being carried out essentially using compressed C | 2009-05-14 |
20090123584 | THERAPEUTIC USES OF TOMATO EXTRACTS - The present invention relates to tomato extracts or an active fraction thereof for use in preventing or inhibiting the initiation of venous thrombosis and fibrin clot formation in a vein. | 2009-05-14 |
20090123585 | TIRE VULCANIZING APPARATUS - A tire vulcanizing apparatus | 2009-05-14 |
20090123586 | Shaping Device for Producing Goods from a Material Strand - A device for shaping products from a material strand comprising two eccentrically circulating separation rings each having cavities and separation ribs. The separation ribs which, during rotation, are moved together to separate individual pieces of the material strand. A rotating stamping chamber ring is provided with open stamping chambers and a pair of stamping dies are sides thereof displaceable into each stamping chamber, one from each side. The stamping dies are driven by a control unit, respectively along a curved path along which the stamping dies are displaceable, when a guiding element defining the curved paths runs about an axis. The dies are fixed to each other in such a way that, during one revolution, stamping of an individual piece begins in a peripheral angle area approximately ranging from 12° to 15° prior to a point of minimum distance between the stamping dies and ends in a peripheral angle area approximately ranging from 0° to 5° after said point of minimum distance between the stamping dies. | 2009-05-14 |
20090123587 | Screw extruder with plunger feeder - The present invention is directed to a materials extrusion device including a screw extruder with a plunger feeder. It includes a screw extruder having a main housing, a materials advancing screw, a screw drive mechanism, a feed port for inputting materials to be extruded and an extrusion outlet port. It also includes a plunger feeder having an elongated, upwardly biased (non-horizontal) plunger housing, e.g., a cylinder, with a plunger. A plunger drive mechanism is connected to the plunger to move the plunger upwardly and downwardly within the plunger housing, and there is a feed outlet at an upper end of the plunger housing, the feed outlet being connected to the screw extruder feed port. | 2009-05-14 |
20090123588 | Apparatus For Forming Structural Members - A method and associated apparatus for forming a composite structural member from a charge are provided. The charge can be disposed on a first die of the apparatus and formed to a desired configuration defined by a recess of the die by inserting a second die or a tool into the recess. In some cases, the first die can include two portions that are adjustable in a transverse direction so that the recess can be opened by the insertion of the second die or tool. The second die or tool can be a substantially rigid member or an inflatable bladder. In either case, the charge can be disposed on the first die, formed, and then further processed on the first die, thereby facilitating indexing of the charge for each operation. | 2009-05-14 |
20090123589 | METHODS INVOLVING MARKING MOLDS - An exemplary method for marking molds, the method comprising, configuring a milling machine to operate with a diamond coated bit having an angle of approximately 60 degrees, and engraving a unique identifier on a bottom surface of a borosilicate glass injection molded soldering mold with the milling machine. | 2009-05-14 |
20090123590 | NANOIMPRINT RESIN STAMPER - A resin stamper is provided that is intended for use in an optical transfer-based nanostructure transfer apparatus and which is capable of automatic transport and alignment. The resin stamper comprises a support member made of a light transmitting material and having mechanical strength, an intermediate layer also made of a light transmitting material, and a patterned resin layer which is also made of a light transmitting material, the support member being larger in size than the intermediate layer and the patterned resin layer, the intermediate layer being more flexible than the patterned resin layer, and the patterned resin layer having a pattern of high and low areas formed in a surface thereof that is the obverse of the pattern of high and low areas in a mold. | 2009-05-14 |
20090123591 | APPARATUS FOR ELECTRO-BLOWING OR BLOWING-ASSISTED ELECTRO-SPINNING TECHNOLOGY AND PROCESS FOR POST TREATMENT OF ELECTROSPUN OR ELECTROBLOWN MEMBRANES - A spinneret format, an electric-field reversal format and a process for post-treatment of membranes formed from electro-spinning or electro-blowing are provided, including a cleaning method and apparatus for electro-blowing or blowing-assisted electro-spinning technology. | 2009-05-14 |
20090123592 | Process for preparing vegetable casing and transferring apparatus used therein - The present invention discloses an extrusion process for preparing vegetable casing including preparing a continuous tubular extrudate by extrusion, and transferring the continuous tubular extrudate. The transferring includes repeatedly passing a plurality of separate horizontal posts below the continuous tubular extrudate, hanging the continuous tubular extrudate on the posts so that the continuous tubular extrudate is conveyed by the posts a distance, while a closed space is formed inside the tubular extrudate and between every two adjacent horizontal posts. | 2009-05-14 |
20090123593 | Film profile forming device - A film profile forming device includes a supporting table, a screw coupled to the supporting table in a perpendicular direction, a motor arranged on an end of the screw for rotating the screw, a guiding base having a screw hole engaged with the screw being driven by the screw for dispersing force and moving in the perpendicular direction, a lower base fixed under the supporting table, and a upper base glidingly arranged between the supporting table and the lower base. The upper base is brought by the guiding base and moves to and fro in the perpendicular direction to close or away from the lower base. | 2009-05-14 |
20090123594 | Filing Assembly - Filling assembly for filling holes formed in a plate, such as a printed circuit board, with a filing material, comprising a support device for supporting the plate, a filling device having a filling material source and a feeding channel connected to the filling material source for feeding filling material from the filling material source to the plate supported by the support device, wherein the feeding channel leads to an output opening held adjoining the plate for filling the filling material into the respective hole of the supported plate, and a vibration device connected to a side wall of the feeding channel, by which the side wall can be vibrated at a particular frequency transverse to the feeding channel, such that the feeding channel is correspondingly diminished at least adjacent to its output opening periodically. | 2009-05-14 |
20090123595 | MOLD FOR FORMING GOLF BALL AND GOLF BALL MANUFACTURED USING THE SAME - There are provided a golf ball molding die in which a mold deposit produced when a gas is discharged can be removed easily, and the area of a venting opening per unit area of the tip end of a pin can be increased tremendously, and a golf ball manufactured by using the golf ball molding die. A golf ball molding die in accordance with the present invention includes at least two die bodies which are configured so that a cavity for forming a golf ball is formed by joining the die bodies to each other; a venting hole which is provided in at least one of the die bodies to discharge a gas in the cavity; and a pin which is present in the venting hole, the pin being configured so that a plurality of layers are lapped on each other from the center thereof. | 2009-05-14 |
20090123596 | Gastro-Activated Dietary Fibers - A gastro-activated dietary fiber comprising an insoluble polysaccharide salt and use of the gastro-activated dietary fiber in ingestible products. The gastro-activated dietary fibers may include salts of biopolymers such as alginates, carrageenans and pectins that are insoluble in water and exhibit minimal or no swelling in water. The water swelling ratio of the gastro-activated dietary fiber may 15 or less. The gastro-activation of the dietary fiber may be induced by exposure to an acidic pH of 3 or less for at least 15 minutes. Ingestible compositions containing the gastro-activated dietary fiber solubilize and provide a viscosity increase in the digestive tract as a result of activation of the dietary fiber by natural excretions of the small intestine which induce gelation of the dietary fiber. Beneficial health effects are potentially obtained by the provision of dietary fiber in this manner, without the usual disadvantages of reduced palatability and poor mouthfeel that are associated with soluble fiber-containing ingestible compositions. | 2009-05-14 |
20090123597 | Fiber containing compositions and methods of making and using same - A composition comprising at least about 25% of a fiber component, by weight of the composition, provides a safe and effective amount of fiber component to a user. A method of producing such a composition is provided. Additionally a method of providing a safe and effective amount of fiber component to a user is provided. | 2009-05-14 |
20090123598 | Process for Production of Beer or Beer-Like Beverage - Disclosed is a process for producing a beer or beer-like beverage having mellowness, a special flavor and a good taste. The beer or beer-like beverage can be produced by allowing a protein deamidase to act on at least a part of a raw material during the production process. | 2009-05-14 |
20090123599 | Cysteine Synthase Gene and Use Thereof - The present invention relates to a brewery yeast having controlled hydrogen sulfide-producing capability, a process for producing alcoholic beverages with controlled hydrogen sulfide amount. More particularly, the present invention relates to a yeast whose hydrogen sulfide-producing capability that increases the product flavor is controlled by enhancing the expression level of YGR012W gene encoding brewery yeast cysteine synthase Ygr012wp, particularly non-ScYGR012W gene specific to lager brewing yeast, and to a method for producing alcoholic beverages with said yeast. | 2009-05-14 |
20090123600 | Method of Producing an Agave-Based Beer-Type Alcoholic Drink - This invention relates to a method of producing a beer-type alcoholic drink, which is based on plants belonging to the genus | 2009-05-14 |
20090123601 | CREAM CHEESE PRODUCT AND ITS METHOD OF PREPARATION - The invention relates to a cream cheese product obtainable by a process comprising the steps of: (a) acidifying a whey protein concentrate with a food grade acidulant or with starter bacteria to reduce the pH to more than 4.5 to about 5.2, (b) heating the acidified whey protein concentrate of step (a) slowly to a temperature of about 75° to about 90° C. and maintaining it for at least about 30 min to produce a 1.5 functional whey protein concentrate, (c) optionally blending the whey protein concentrate of step (b) with milk fat in a weight ratio of about 60:40 to about 100:0 wherein step (c) may be carried out before step (b), (d)=homogenizing the blend obtained in step (b) or (c) in a 2-stage high-pressure homogenizer at pressures of about 300-400/50-80 bar and a temperature of about 5° to about 75° C. to produce an emulsified functional whey protein concentrate, (e) blending the product of step (d) with curd the fat content of which is adjusted in accordance with the milk fat portion added in step (c) and with the desired product, and adding salt and optional stabilizers, and (f) homogenizing the product of step (e) in a 2-stage high pressure homogenizer at pressures of about 300-400/508-80 bar and at a temperature of about 68° to about 90° C. | 2009-05-14 |
20090123602 | METHOD FOR MAKING LACTOSE-REMOVING MILK - A method for removing lactose from milk comprising the steps of precipitation, ultrafiltration, re-dissolving, mixing, and restoration, with or without a step of degreasing prior to precipitation. The lactose-removed diary product can be liquid milk, milk powder, or combined with other products to make sugar-free or low-sugar healthy food. The milk used in the method can be milk from any mammals or milk obtained by dissolving milk powder in drinking water. | 2009-05-14 |
20090123603 | METHODS OF MAKING SYRUPS - Provided herein are methods of making a substantially clear syrup comprising reacting one or more substrates at a concentration of at least 40% w/w with at least one alternan sucrase enzyme at a temperature of greater than 45° C. | 2009-05-14 |
20090123604 | EMULSION FOOD INGREDIENT - An oil-in-water emulsion for use as a cream substitute in the food industry is provided. The oil-in-water emulsion is based on a mixture of vegetable, marine and/or fish oil(s), milk protein and water. The emulsion can further comprise optional lipophilic and hydrophilic constituents. The emulsion of the present invention contains reduced amounts of saturated fat, cholesterol, trans fatty acids and is preferably further fortified with poly-unsaturated fatty acids (PUFAs). The emulsion is a suitable cream substitute which remains stable when heated and/or when in contact with strongly acidic or alcoholic ingredients. A method to prepare the emulsion is also provided. | 2009-05-14 |
20090123605 | Food Products Comprising Hydrolysed Milk Solids With Improved Taste - Food products comprising hydrolysed milk solids, especially tripeptides such as IPP, VPP, LPP are known to lower blood pressure. However they show an undesirable off taste. This can be remedied by the addition of sterol or stanol fatty acid esters to the food products. Preferred food products are emulsions. A further benefit of these products is that they may also reduce blood cholesterol levels. | 2009-05-14 |
20090123606 | Carbohydrate modifying agent and drinks containing the modifying agent - A carbohydrate modifying formulation that modulates the rate of sugar absorption and/or metabolism in a subject to whom the formulation is administered. In one embodiment, the formulation comprises an active soluble fiber, one or more polyphenolic compounds, an aqueous diluent, and sugar. In another embodiment, the formulation is a dry powder that comprises an active soluble fiber, antioxidant containing botanical extracts, crystalline fructose, a probiotic, vitamins and minerals. | 2009-05-14 |
20090123607 | Self-rising dough-containing food product and related manufacturing methods - A self-rising dough-containing food product, particularly pizza, in which a non-yeast containing leavening system is combined with an uncooked dough in the presence of a moisture retention agent and dough conditioners to provide a frozen raw food product that may be cooked directly from the freezer in a microwave oven. The dough in the self-rising dough containing food product reaches full development in shorter mixing times at lower mixing speeds than conventional dough-containing products. | 2009-05-14 |
20090123608 | Edible product containing beneficial moulds and/or yeasts - The present invention provides a method of preparing an edible product comprising non-viable moulds and/or yeasts that are substantially structurally intact and which provide a health benefit, the method comprising subjecting viable moulds and/or yeasts to at least two sub-lethal treatments to obtain the non-viable moulds and/or yeasts providing a health benefit, each sub-lethal treatment on its own not being sufficient to render the moulds and/or yeasts non-viable. | 2009-05-14 |
20090123609 | METHODS OF PREPARING A LIQUID SUSPENSION FOR USE WITH ANIMAL FEED - Methods of preparing a liquid suspension are provided. According to one aspect, the method includes mixing, simultaneously or in separate steps, at least: (a) a liquid source of digestible organic matter, wherein the liquid source of digestible organic matter includes: (i) water in a concentration of at least 25% by weight of the liquid source of digestible organic matter; and (ii) digestible organic matter in a concentration of at least 5% by weight of the liquid source of digestible organic matter, wherein the digestible organic matter comprises starch in a concentration of at least 10% by weight on a dry-matter basis. The liquid source of digestible organic matter is mixed with: (b) an alkali or alkali source and/or (c) a water-insoluble material selected from the group consisting of a nutrient, a medicament, and any combination thereof in any proportion. The mixing proportions and conditions are selected to obtain a resulting mixture have desirable dry-matter content and physical characteristics. | 2009-05-14 |
20090123610 | SALEABLE COGNITIVE PERFORMANCE SNACK FOOD ITEMS AND METHODS OF PREPARING, PACKAGING AND USING SAME - A method of providing a cognitive performance snack food to a user includes producing a multitude of snack food pieces, placing the multitude of snack food pieces in a snack packaging adapted to be opened and closed with one hand, and providing a saleable performance snack food item to consumers for use during computer or video game activity. Each snack food piece including a snack food base and a mixture of cognitive performance additives. The snack pieces and snack packaging together define the saleable performance snack food item, which can be consumed with one hand and while operating computer or video gaming equipment. | 2009-05-14 |
20090123611 | Printed sterilizable laminate for aseptic packaging - A printed sterilizable laminate for aseptic packaging includes two films each including a core layer including ethylene vinyl alcohol copolymer, polymeric adhesive, or polyamide; first and second intermediate layers each including a polyamide; an outer layer including amorphous cyclic olefin copolymer, or a blend of amorphous cyclic olefin copolymer and at least one olefinic copolymer; an inner layer including olefinic copolymer, or a blend of an olefinic copolymer and amorphous cyclic olefin copolymer; and first and second tie layers adhering the intermediate layers to the outer and inner layers respectively; a printed image disposed on the outside surface of the first film, or the inside surface of the second film; and an adhesive that bonds the outer layer of the first coextruded film to the inner layer of the second coextruded film. An aseptic package, and a method of making an aseptic package are also disclosed. | 2009-05-14 |
20090123612 | TEA BEVERAGE PACKED IN CONTAINER - Provided is a packaged tea beverage which has good flavor and is compositionally excellent in storage stability. The packaged tea beverage comprises a tea extract having a ratio of gallate-type catechins in non-polymer catechins of less than 50% by mass added to a tea extract liquid, and (A) 0.072 to 0.4% by mass of non-polymer catechins and (B) 21 to 150 ppm of gallic acid, wherein a ratio of gallate-type catechins in non-polymer catechins is 0 to 50% by mass and a ratio of epi-type catechins in non-polymer catechins is 30 to 60% by mass. | 2009-05-14 |
20090123613 | HIGH MODULUS IONOMERS FOR PACKAGING - A multilayer packaging film or sheet is disclosed. The film comprises at least one layer comprising or produced from an olefin copolymer, a composition, or combinations thereof in which the composition comprises the olefin copolymer and a polyamide, a barrier resin, a polyolefin, a vinyl ester copolymer, a carboxylate ester copolymer, or combinations of two or more thereof and the olefin copolymer is a magnesium-neutralized ionomer and comprises repeat units derived from an α-olefin and a comonomer including one or more α-, β-ethylenically unsaturated carboxylic acids. Further disclosed is a shaped article comprising or produced from the packaging film or sheet and packaged food. | 2009-05-14 |
20090123614 | PACKAGING WHICH IS SUITABLE FOR MICROWAVES - A packaging suitable for microwaves and made of plastic film, having a packaging recess in which a packaged product is introduced, and of a closing film which is sealed on a margin of the packaging recess along a sealing seam, the margin having a region which is formed as a duct and is initially closed and through which, after opening along a weakening line, steam can escape during the heating of the packaged product. A method for heating the packaged product in the packaging is also disclosed. | 2009-05-14 |
20090123615 | Composition Derived from a Meat Source and Processes for Making and Using Composition - A composition is derived from animal muscle may be added to a substrate animal muscle for improving water-binding capacity of the substrate animal muscle. A process for making a composition in accordance with one embodiment may include the steps of providing a slurry of animal muscle and water; increasing the pH of the slurry to an alkaline level sufficient to solubilize at least a portion of the animal protein in the animal muscle so as to form an alkaline slurry; and maintaining the pH of the alkaline slurry at a level sufficient to prevent coagulation of the animal protein. The alkaline slurry may then be dried to form a substantially dry particulate animal muscle product. The particulate animal muscle product may then be reconstituted to form a marinade, and the marinade may be applied to a substrate animal muscle. | 2009-05-14 |
20090123616 | Apparatus for Applying Coating to Products and Methods of Use Thereof - An apparatus and method for coating products is disclosed herein. An exemplary apparatus comprises a vibration generating portion and a product coating portion. The product coating portion can include a coating application portion, a sifting portion, and an aligning portion. The exemplary apparatus can include a coating recycle portion as well. The vibration generation portion further comprises a motor vibration assembly secured to a frame wherein the frame is in communication with the product coating portion, such as a pan assembly, by springs that move the pan assembly with a vibratory motion. The product coating portion includes a series of angled steps that guide the coating and vibrating product upwards and forward, while simultaneously allowing the product to be agitated against the coating resting on the step surface. Additionally, the product coating portion can include a moveable wire belt conveyor assembly. | 2009-05-14 |
20090123617 | Syrup concentrate for a frozen carbonated beverage - A syrup for a frozen carbonated beverage has a freezing point suppressant, which can be a sugar or sugar substitute mixed with sucralose. The syrup contains a gelling agent, a foaming agent and an acidic agent that facilitate forming a slushy frozen beverage suitable of being dispensed from a mechanical beverage dispenser having a mixing and chilling chamber after being mixed with carbon dioxide. | 2009-05-14 |
20090123618 | Soy Milk Compositions and Methods of Preparation - Soy milk and beverage compositions together with methods for preparation, such compositions utilizing soy particulates of consistent micron dimension, either alone or in conjunction with high process pressures, to provide texture and taste characteristics. | 2009-05-14 |
20090123619 | SHORTENINGS AND METHODS OF MAKING AND USING THEREOF - Described herein are shortenings with improved properties such as increased hardness, minimal trans fat, and reduced saturated fats. Methods for preparing the shortenings involve the use of one or more structural enhancers in a vegetable oil followed by processing and tempering the admixture. The shortenings can be used to produce food products with reduced saturated fats and increased hardness as well as minimal trans fats. | 2009-05-14 |
20090123620 | Automated Application of an Antimycotic Composition to Sliced Foodstuffs and an Antimycotic Application Apparatus - A method for applying a powdered antimycotic composition to a foodstuff, the method including mixing a powdered antimycotic composition in an air stream, applying a uniform coating of antimycotic composition to each surface of a bulk foodstuff and slicing the foodstuff into a plurality of slices having the desired antimycotic surface concentration on each surface thereof. | 2009-05-14 |
20090123621 | Feed additive and a method for the production thereof - The method for producing the feed additive based on the processed conifer needle extracts, which is unique, because it uses the microgranulation of the neutralized conifer needle extract and a water-soluble polymer matrix/binding agent in the form of an aqueous solution, which is combined with the extract; this mixture is then added dropwise to an aqueous solution of a crosslinking agent, whereby sodium alginate or a protein/anionic polysaccharide complex, consisting of gelatin and sodium alginate, is used as the polymer matrix/binding agent, and water-soluble calcium salts are used as the crosslinking agent (the calcium salts ensure the obtainment of an insoluble matrix of microgranules), or a protein/anionic polysaccharide complex, consisting of gelatin and sodium alginate, is used as the polymer matrix/binding agent and water-soluble iron salts are used as the crosslinking agent (the iron salts ensure the obtainment of an insoluble matrix of microgranules). | 2009-05-14 |
20090123622 | PROCESS AND DEVICE FOR DEHUSKING CEREAL GRAINS - The invention relates to a method and a system for dehusking grains, in particular for removing the spelts and/or the seed coat and the germ bud of grains and/or of malted grains and its processing in the brewing industry. The outer layers/shells are removed from cleaned and malted distiller's grains in a husking machine ( | 2009-05-14 |
20090123623 | Food dicer - A dicing tool having: a foodstuff holder for holding a block of foodstuff and a cutting base; the cutting base having: a rectangular framework for sliding the foodstuff holder therealong; a first part having an triangular shaped front edge, equally spaced triangular cutting blades being arranged in a triangular arrangement that follows the profile of the triangularly shaped front edge; a handle; a second part having a second upper surface and a right front edge and a left front edge arranged in a deep V shape, with continuous blades attached to the right and left front edges; wherein the second upper surface is always parallel to the first surface and can be slidingly reciprocated between an upper position and a lower position where the horizontal blade is substantially on a level with the first surface and the base of the triangular cutting blades. | 2009-05-14 |
20090123624 | OMELET SPATULA AND COOKING METHOD - An omelet spatula includes a handle and a body. The body is attached to the handle and includes a surface in the shape of half of a cooking food, having an inner edge and an outer edge that meet at each end. The shape of the spatula allows the user to easily fold the cooking food over itself, for example, as when cooking an omelet. The spatula is configured to remain in the cooking pan, underneath half of the omelet, until the omelet is folded. Also, a cooking method using the spatula is described. | 2009-05-14 |
20090123625 | PAN FOR BAKING - A pan is for making baked products. The pan comprises an upper surface and a plurality of receptacles for receiving batter. Each receptacle has one or more side walls extending from a bottom wall to the upper surface. Each receptacle is configured to cause a product baked therein to be crispy around the entire periphery of the product | 2009-05-14 |
20090123626 | REDUCED ACRYLAMIDE PLANTS AND FOODS - The present invention relates to genetic methods for down-regulating and up-regulating genes in a plant, for example in the starch-rich storage organs of these plants, as well as the products of these plants, to lower the level of acrylamide that accumulates upon processing-associated heating of these organs and plant products. | 2009-05-14 |
20090123627 | Gluten-free flour composition - A gluten-free flour composition for persons with celiac disease or other gluten sensitivity comprising specified quantities of gluten-free white rice flour, gluten-free potato starch, gluten-free corn starch, gluten-free tapioca starch, gluten-free corn flour, and xanthan gum, all mixed thoroughly in dry form and packaged. The gluten free flour mix closely emulates all-purpose wheat flour in taste, consistency, volume, loft and texture, and is suitable as a 1-for-1 substitute for all purpose wheat flour in conventional wheat flour recipes to produce gluten-free breads, cookies, cakes, muffins, sauces, roux, batter and any other type of flour-containing food products. | 2009-05-14 |
20090123628 | LOW ACYL GELLAN GELS WITH REDUCED THERMAL HYSTERESIS AND SYNERESIS - The present invention provides a composition of matter where gelatin-like gels with little thermal hysteresis and syneresis are prepared from water, low acyl gellan gum, and tamarind seed xyloglucan. The composition may further include salts up to an amount equivalent to the ionic strength of 30 mM. The gel exhibits a thermal hysteresis as defined as the difference between gel setting and melting temperatures typically less than about 5° C. and no appreciable syneresis. Methods for preparing gels having storage modulus values in the order of 100 Pa and 1,000 Pa and melting temperatures of about 30° C. and 40° C., respectively, are also disclosed. | 2009-05-14 |